13F Holdings
中文EN

CBDY Target Group Inc.

Medicinal Chemicals & Botanical Products · OTC · SEC CIK 1586554 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.1%
TTM net income YoY-155.4%
TTM EPS YoY-150.0%
Revenue 3-yr CAGR40.5%
Net income 3-yr CAGR—

Margins

Gross margin42.0%
Operating margin—
Net margin-30.2%
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-24.6%
ROIC (approx.)—
Asset turnover0.82x

Leverage & solvency

Liabilities / assets245.5%
Debt / equity—
Current ratio0.20x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.18x
Accruals ratio-20.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$3.88M$6.59M$3.72M$0$0
Cost of revenue$1.81M$2.87M$2.07M$0—
Gross profit$2.07M$3.73M$1.66M$0—
Interest expense$1.04M$1.15M$1.41M$1.12M$985,634
Pretax income-$1.36M$160,504-$323,670-$4.52M$272,881
Income tax$0$0$0$0$0
Net income-$1.36M$160,504-$323,670-$4.52M$272,881
EPS (basic)-0.000.00-0.00-0.010.00
EPS (diluted)-0.000.00-0.00-0.010.00
Weighted avg. shares (diluted)617.03M727.23M617.03M617.03M595.35M
Balance sheet
Cash & equivalents$108,800$1.88M$745,019$232,333$122,151
Receivables$446,283$77,092$1.03M$2,068$2,068
Inventory$1.67M$882,279$1.22M$0$99,000
Current assets$2.33M$3.10M$3.09M$909,987$584,222
PP&E, net$3.55M$4.19M$5.43M$5.55M$6.84M
Goodwill$260,016$247,685$269,460$263,117$3.68M
Total assets$6.18M$7.57M$8.84M$7.57M$13.06M
Current liabilities$13.38M$13.10M$14.59M$6.93M$4.04M
Short-term debt$7.60M$7.24M$7.88M$1.74M$601,641
Long-term debt$7.60M$7.24M$7.88M$5.96M$7.76M
Total debt$15.21M$14.49M$15.76M$7.69M$8.36M
Total liabilities$14.24M$14.08M$15.81M$14.13M$15.22M
Shareholders' equity-$8.06M-$6.51M-$6.97M-$6.56M-$2.15M
Net debt$15.10M$12.61M$15.02M$7.46M$8.24M
Shares outstanding617.03M617.03M617.03M617.03M617.03M
Cash flow statement
Operating cash flow-$842,425$2.16M-$589,612-$1.01M$100,118
Investing cash flow$81,379-$178,978$416,932$1.02M-$1.41M
Financing cash flow-$1.06M-$730,225$666,900$122,674$1.25M
Depreciation & amortization$898,403$916,213$811,649$885,229$971,524

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.